At a glance
- Originator Roussel-Morishita
- Class Antineoplastics
- Mechanism of Action Aromatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 05 Aug 1998 No-Development-Reported for Cancer in Japan (Unknown route)
- 11 Apr 1996 Preclinical development for Cancer in Japan (Unknown route)